THE COMPLETE GUIDE TOANTI-AGING ANDBIOHACKING

Cited daily costs with compared lifestyle activities, Bringing awareness of the daily cost on average.

IMPORTANT DISCLAIMER

THIS DOCUMENT IS FOR EDUCATIONAL PURPOSES ONLY.
The information in this guide helps you understand what anti-aging interventions and peptides are and what they’re used for. This is NOT medical advice. Always talk to your doctor beforetrying any supplements, diets, or treatments mentioned here. We are not responsible for any effects from using this information. What works for one person may not work for another

WHAT’S HAPPENING IN ANTI-AGING TODAY (2024-2025)

The anti-aging field is exploding with new discoveries. In 2024, investors put $8.5 billion into longevity research – more than double the previous year (PR Newswire, 2024). Four FDA-approved drugs now show real anti-aging benefits, and several breakthrough therapies are entering human trials. The bottom line: You can get 80% of anti-aging benefits fromsimple lifestyle changes that cost less than $500 per year. The expensive, high-tech treatments only add the remaining 20%.

PART 1: FDA-APPROVED MEDICATIONS THAT FIGHT AGING

[Chart: Comparison of FDA-Approved Anti-Aging Medications] Four medications already approved by the FDA show proven anti-aging benefits according to Dr. Nir Barzilai from Albert Einstein College of Medicine (Fortune, 2024; NAD.com, 2024):

1. METFORMIN – THE AFFORDABLE OPTION

What it does: Originally for diabetes, it activates longevity
pathways in your cells
Cost: $4-20 per month ($0.13-0.67 per day)
Evidence: People taking it have lower death rates from all causes (Fortune, 2024)
Current research: The TAME trial is testing it specifically for aging in 3,000 people (Aviv Clinics, 2024)

2. GLP-1 DRUGS (OZEMPIC, WEGOVY)

What they do: Control blood sugar and reduce appetite
Benefits beyond weight loss: Lower risk of heart disease, kidney disease, and possibly Alzheimer’s
Cost: $800-1,200 per month ($26-40 per day)
Evidence: 10/12 effectiveness score for longevity (NAD.com, 2024)